Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
MIRAEAMC - MAM150ETF

MIRAEAMC - MAM150ETF

NSE: MIDCAPETF
SMALL CAPMCap –
₹22.24₹0.04 (+0.18%)

Market Closed • NSE

Market cap–
Enterprise value–
52W high₹24.57
52W low₹19.60
Price chart(1Y)
1Y Return:-0.71% (₹0.16)
H: ₹24.57L: ₹21.7
1W+0.72%
1M-3.72%
3M-5.68%
6M-1.24%
1Y+0.59%
Today at a glance

Day range

₹22.11₹22.45

52 week range

₹19.60₹24.57
Volume1.77M0.70x 20D avg
Free float50.00%-29.80% volume

MIRAEAMC - MAM150ETF closed at INR22.24 (+0.18%) on volume 0.7x its 20-day average, trading 9.48% below its 52-week high.

Technical analysis
RSI (14)38.6Neutral (30–70)
MACDBULLISHBullish (Above signal)
ATR (14)₹0.49Moderate
SMA 20₹22.55BEARISH
SMA 50₹23.28BEARISH
SMA 100₹23.27BEARISH
SMA 200₹22.67BEARISH
CPR bottom₹22.52
Pivot₹22.42
CPR top₹22.31
Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
PENDING_DATA3/4 criteria
Pending Data
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio––—≤ 33%PENDING_DATA
Non-halal income ratio––0.00%≤ 5%PASS
Illiquid assets ratio––—≥ 20%PASS
Receivables ratio––—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E—25.00
Forward P/E——
P/B—3.50
EV/EBITDA—18.00
PEG—1.50
Earnings yield—4.00
Growth & profitability
RevenuePAT

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y—
Revenue CAGR 5Y—
PAT CAGR 3Y—
PAT CAGR 5Y—
Operating margin0.00%
Net margin0.00%
Financial health & cash flow
Net debt–Moderate
Interest coverage—xEBIT / interest
CFO / PAT—x3Y average
Net debt / EBITDA—Leverage
Operating cash flow–
Capital expenditure–
Free cash flow–
Fundamental scorecard
Overall50/100
Valuation50/100
Profitability50/100
Financial health50/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Established operational history in the sector

Active institutional participation

Risks

Subject to cyclical raw material and macro industry pressures

Bull case

Market Leadership: Established operational scale in core business.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Delivery participation

Traded volume and delivery percentage across the latest 20 sessions

Average delivery (20D)69.68%+1.19% latest vs average
Highest delivery80.36%on 25 Sept
Average volume (20D)2.52MTrading-session average
Conviction trendStrengthening+1.19% latest reading
Traded volumeDelivery %
Questions investors ask
Is MIRAEAMC - MAM150ETF Shariah compliant?

MIRAEAMC - MAM150ETF is currently screened as Pending Data under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Interest-bearing debt or Market Cap data unavailable for ratio screening. Financial ratio screening incomplete due to missing balance sheet or market cap data.

What is MIRAEAMC - MAM150ETF's current valuation relative to peers?

MIRAEAMC - MAM150ETF trades at a P/E of N/A compared to the sector median of 25x, and a Price-to-Book of N/A.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of zero debt. Interest coverage is comfortable.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at steady rates while net profit growth averaged consistent levels.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.